|
||||||||||||||||||||||||||||||||
| Screenreader-optimized Version for visually impaired and blind visitors |  Home |
|
| | |
Accessibility | |
| | |
Zoom version | |
| | |
Local Sitemap | |
| | |
eng | |
deu | |
||||||||||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
Statement of Cash Flows (unaudited)
| Spreadsheets |
| For the nine-month period ended | ||
|---|---|---|
CHF million | 30.9.05 | 30.9.04 |
Cash flow from/ (used in) operating activities | ||
Net profit | 8,041 | 6,260 |
Adjustments to reconcile net profit to cash flow from/ (used in) operating activities |
|
|
Non-cash items included in net profit and other adjustments: | ||
Depreciation of property and equipment | 1,161 | 1,133 |
Amortization of goodwill and other intangible assets | 244 | 732 |
Credit loss expense / (recovery) | (243) | (142) |
Equity in income of associates | (152) | (56) |
Deferred tax expense / (benefit) | 37 | 64 |
Net loss / (gain) from investing activities | (661) | (486) |
Net loss / (gain) from financing activities | 2,314 | 780 |
Net (increase) / decrease in operating assets: | ||
Net due from / to banks | 23,288 | 5,800 |
Reverse repurchase agreements and cash collateral on securities borrowed | (179,893) | (74,914) |
Trading portfolio and net replacement values | (67,319) | (34,596) |
Loans / due to customers | 27,854 | 3,899 |
Accrued income, prepaid expenses and other assets | (1,857) | (8,989) |
Net increase / (decrease) in operating liabilities: | ||
Repurchase agreements, cash collateral on securities lent | 122,466 | 51,775 |
Accrued expenses and other liabilities | 14,912 | 23,151 |
Income taxes paid | (1,648) | (1,099) |
Net cash flow from/ (used in) operating activities | (51,456) | (26,688) |
Cash flow from/ (used in) investing activities | ||
Investments in subsidiaries and associates | (658) | (1,427) |
Disposal of subsidiaries and associates | 905 | 697 |
Purchase of property and equipment | (1,272) | (844) |
Disposal of property and equipment | 496 | 705 |
Net (investment in) / divestment of financial investments | (586) | 784 |
Net cash flow from/ (used in) investing activities | (1,115) | (85) |
Cash flow from/ (used in) financing activities | ||
Net money market paper issued / (repaid) | 31,687 | 28,655 |
Net movements in treasury shares and own equity derivative activity | (1,041) | (4,079) |
Capital issuance | 1 | 2 |
Dividends paid | (3,105) | (2,806) |
Issuance of long-term debt, including financial liabilities designated at fair value | 63,003 | 44,045 |
Repayment of long-term debt, including financial liabilities designated at fair value | (25,641) | (20,315) |
Increase in minority interests1 | 1,552 | 7 |
Dividend payments to / purchase from minority interests | (416) | (215) |
Net cash flow from/ (used in) financing activities | 66,040 | 45,294 |
Effects of exchange rate differences | 5,677 | 551 |
Net increase / (decrease) in cash and cash equivalents | 19,146 | 19,072 |
Cash and cash equivalents, beginning of the period | 87,091 | 73,356 |
Cash and cash equivalents, end of the period | 106,237 | 92,428 |
Cash and cash equivalents comprise: |
|
|
Cash and balances with central banks | 6,689 | 3,884 |
Money market paper2 | 58,590 | 53,932 |
Due from banks maturing in less than three months | 40,958 | 34,612 |
Total | 106,237 | 92,428 |
Cash paid for interest was CHF 30,435 million and CHF 17,252 million during the first nine months of 2005 and 2004, respectively.
Top
Important legal information - please read the disclaimer before proceeding.
Products and services in these webpages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2009. All rights reserved.
Privacy Policy
